Betaxolol (Kerlon)

Subscribe to Selected New Research on Betaxolol

263 relevant articles (25 outcomes, 60 trials/studies) found for this Drug

Description: A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.

Also Known As:

Kerlon; Betoptic; ALO-1401-02; Alcon Brand of Betaxolol Hydrochloride; Allphar Brand of Betaxolol Hydrochloride; Betaxolol Alcon; Betaxolol Hydrochloride; Betoptima; Boots Brand of Betaxolol Hydrochloride; Kerlone; Lorex Brand of Betaxolol Hydrochloride; Oxodal; SL-75212; Schwarz Brand of Betaxolol Hydrochloride; Searle Brand of Betaxolol Hydrochloride; Synthelabo Brand of Betaxolol Hydrochloride; Synthélabo Brand of Betaxolol Hydrochloride; ALO 1401 02; ALO140102; Alcon, Betaxolol; Hydrochloride, Betaxolol; SL 75212; SL75212; 2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-

Relationship Network

Drug Context: Research Results

Experts

1.	Sidorenko, B A: 2 articles (01/2008 - 01/2005)
2.	Ageev, F T: 2 articles (01/2006 - 01/2005)
3.	Kural, Gülcan: 2 articles (05/2004 - 05/2003)
4.	Yarangümeli, Alper: 2 articles (05/2004 - 05/2003)
5.	Hirai, Tadakazu: 1 article (05/2008)
6.	Fujita, Masatoshi: 1 article (05/2008)
7.	Hosokawa, Ryohei: 1 article (05/2008)
8.	Senda, Shoichi: 1 article (05/2008)
9.	Takeishi, Yasuchika: 1 article (05/2008)
10.	Takase, Bonpei: 1 article (05/2008)

Related Diseases

1.	Hypertension (High Blood Pressure) 01/01/2004 - "The aim of this single-blind study was to compare the efficacy of betaxolol treatment (20 mg/day) on 24-h blood pressure profiles in working men and women with mild hypertension (grade 1 acc" 01/01/1998 - "AIM: To study efficacy and tolerance of cardioselective beta-adrenoblocker lokren (betaxolol) in elderly patients with mild and moderate hypertension" 10/19/1997 - "The efficacy and safety of daily 20 mg betaxolol monotherapy was investigated in mild-moderate essential hypertension in a four week long, open label, single blind trial (with a placebo run-in)" 04/01/1992 - "This study determined the dose-response relationship among three doses of betaxolol compared with placebo in patients with mild-to-moderate hypertension" 07/01/1989 - "Open trial of betaxolol in the treatment of arterial hypertension in pregnancy, pilot study]" Order ALL the reference details at left...
2.	Glaucoma 10/01/2001 - "In addition, two cases are reported of the occurrence of clinical depression following use of topical betaxolol which only resolved completely after switching glaucoma medication" 01/01/2002 - "RESULTS: Betoptic S treatment in patients with open-angled glaucoma in early stages was efficient; therefore ocular pressure values continued in normal limits and visual capacity at automatic perimetry was improved" 02/01/1995 - "CONCLUSIONS: Betaxolol appears to be an effective and well tolerated ocular hypotensive agent in a typical glaucoma population, which includes many patients with cardiopulmonary disease" 08/01/1986 - "Betaxolol hydrochloride is a topical beta 1-blocking agent that has been found to be safe and effective in lowering intraocular pressure (IOP) in patients with glaucoma" 01/01/2002 - "CONCLUSIONS: 1. Betoptic S neuroprotector effect is obvious in early glaucoma patients; visual capacity was improved in all cases" Order ALL the reference details at left...
3.	Ocular Hypertension (Glaucoma, Suspect) 03/01/2003 - "Results of the betaxolol versus placebo treatment trial in ocular hypertension." 01/01/1994 - "This study demonstrated that betaxolol increases RBF in eyes with ocular hypertension; this increase is probably related to the increase in perfusion pressure." 04/01/1984 - "Betaxolol, a new beta 1-adrenergic blocker, was applied to 20 eyes of ten patients with ocular hypertension" 07/01/1990 - "Thus, betaxolol is an alternative therapeutic option available to the physician for the management of chronic open-angle glaucoma and ocular hypertension" 03/01/2003 - "PURPOSE: To determine whether treatment with betaxolol can delay or prevent the conversion from ocular hypertension to early glaucoma on the basis of visual field criteria, by means of a prospective, randomised, placebo-controlled trial" Order ALL the reference details at left...
4.	Open-Angle Glaucoma (Glaucoma, Open Angle) 05/15/1986 - "Betaxolol appears to be a clinically effective and safe agent in the treatment of open-angle glaucoma" 01/01/1992 - "Effect of instillations of 0.5% betaxolol solution (Alcon) on intraocular pressure, ocular hydro- and hemodynamics, function, systemic arterial pressure, and pulse was studied in 35 patients (57 eyes) with primary open-angle glaucoma" 07/01/1990 - "Thus, betaxolol is an alternative therapeutic option available to the physician for the management of chronic open-angle glaucoma and ocular hypertension" 08/15/1990 - "In 352 patients with primary open-angle glaucoma or ocular hypertension, a multicenter double-masked, parallel-group clinical study compared the effects on intraocular pressure and ocular comfort of 0.5% betaxolol ophthalmic solution, a cardioselective beta-adrenergic blocking agent, with 0.25% betaxolol suspension" 06/01/1998 - "Effect of betaxolol on primary open-angle glaucoma and normal-tension glaucoma patients." Order ALL the reference details at left...
5.	Angina Pectoris 05/01/1990 - "The results indicate that betaxolol, in widely ranging doses, is highly effective in reducing angina pectoris frequency and improving exercise capacity in patients with stable exertional angina pectoris." 05/01/1990 - "Efficacy of betaxolol in the treatment of stable exertional angina pectoris: a dose-ranging study." 05/01/1990 - "To assess the efficacy of oral betaxolol in the treatment of stable exertional angina pectoris and to determine the relationship between betaxolol doses/serum concentrations and clinical/hemodynamic responses the authors studied 24 patients prior to and following stepwise administration of 5, 10, 20, 40, and 80 mg doses" 03/01/1987 - "This study examined the effects of beta blockade with betaxolol, a cardioselective, lipid-soluble, beta-adrenergic-blocking agent, on rest and exercise systolic and diastolic left ventricular function in 15 patients, aged 40 to 70 years (mean = 52), with chronic stable angina pectoris" 01/01/1994 - "Betaxolol in the treatment of stable angina pectoris." Order ALL the reference details at left...

Related Drugs and Biologics

1.	brimonidine (Alphagan)
2.	Propranolol (Inderal)
3.	Adrenergic Antagonists (Antiadrenergic Agents)
4.	Timolol (Blocadren)
5.	Sotalol (Sotalol Hydrochloride)
6.	Cytochrome P-450 CYP2D6 (CYP2D6)
7.	Levobunolol (AKBeta)
8.	Epinephrine (Adrenaline)
9.	Nitroglycerin (Dynamite)
10.	Cytochromes

Related Therapies and Procedures

1.	Trabeculectomy (Trabeculoplasty)
2.	Radial Keratotomy
3.	Lasers (Laser)
4.